Cluster 3 (n = 95) comprised patients with low miR-375 expression and low IRS1 and AKT2 activity, poor glucose control, and the lowest adherence, as well as the most cardiovascular disease and nephropathy. Here, AKT2 is linked to cardiovascular disorder.